Back

Incidence and prevalence of hypertrophic cardiomyopathy in Sweden during the years 2003-2022, a nationwide observational study

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Hypertrophic cardiomyopathy (1) Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Jonas Silverdal

Sahlgrenska University Hospital, Gothenburg (Sweden)

3 More presentations in this session

Presentation thumbnail
Implication of angio-based microvascular resistance for atrial fibrillation in patients with hypertrophic cardiomyopathy
Doctor Y. Pei (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Hypercontractile phenotype in hypertrophic cardiomyopathy correlate with adverse systemic and coronary parameters
Professor K. Wierzbowska-Drabik (Lodz, PL)
Abstract Slides Video
Presentation thumbnail
Pharmacogenetics for mavacamten treatment individualization in patients with obstructive hypertrophic cardiomyopathy
Doctor C. Lucas (Marseille, FR)
Abstract Slides Video

Access the full session

Session thumbnail
Hypertrophic cardiomyopathy (1)

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Session
Precision medicine in hypertrophic cardiomyopathy
thumbnail
Congress Presentation
Comparison of characteristics and outcomes of patients with obstructive vs. non-obstructive hypertrophic cardiomyopathy in a cohort from a referral center in colombia
thumbnail
Congress Presentation
Temporal trends in the incidence and mortality of calcified arotic valve disease in the nordic countries over the past 30 years

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources